Considering the production of the differentiated epithelial cell marker Krt20 (Fig. 7AB), it could be concluded that a method mimicking the suppression of Tcf7l2 expression (inhibition of the Wnt pathway) could be a therapeutic approach to the treatment of colorectal tumors. The gene discussed is TCF7L2; the disease is colorectal neoplasm.